Digital Technologies And Life Sciences Will Open New Markets

AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
Published
06 Aug 24
Updated
31 Jul 25
AnalystConsensusTarget's Fair Value
US$279.35
6.6% undervalued intrinsic discount
31 Jul
US$261.01
Loading
1Y
12.9%
7D
-3.3%

Author's Valuation

US$279.4

6.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 1.92%

Shared on30 Apr 25
Fair value Increased 0.46%

AnalystConsensusTarget has increased revenue growth from 4.1% to 4.7%.

Shared on23 Apr 25
Fair value Decreased 1.22%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.

Shared on16 Apr 25
Fair value Decreased 2.32%

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 0.73%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 0.36%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 4.09%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.